Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Townsend, Tristan, Razanskaite, Violeta, Dodd, Susanna ORCID: 0000-0003-2851-3337, Storey, Daniel, Michail, Stephanie, Morgan, James, Davies, Michael, Penman, Douglas, Watters, Christopher, Swaminathan, Mira
et al (show 7 more authors) (2020) Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease. Alimentary Pharmacology and Therapeutics, 52 (8). pp. 1341-1352.


Burkitt, Michael D ORCID: 0000-0002-5055-6408, Williams, Jonathan M, Townsend, Tristan, Hough, Rachael and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2017) Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration. CELL DEATH & DISEASE, 8 (7). e2939-.


Burkitt, Michael ORCID: 0000-0002-5055-6408, Williams, Jonathan, Townsend, Tristan, Hough, Rachael, Duckworth, Carrie and Pritchard, David Mark ORCID: 0000-0001-7971-3561
(2017) Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration. Cell Death and Disease. 112656-.


Townsend, Tristan, Campbell, Fiona, O'Toole, Paul and Probert, Chris ORCID: 0000-0003-4550-0239
(2019) Microscopic colitis: diagnosis and management. FRONTLINE GASTROENTEROLOGY, 10 (4). pp. 388-393.


Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg-Bartolo, Simon
et al (show 11 more authors) (2022) A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55 (7). pp. 856-866.

This list was generated on Mon Mar 25 11:25:10 2024 GMT.